Skip to main content

A Phase 3, Randomized, Multicenter, Multinational, Double-Blinded Study Comparing the Efficacy and Safety of Repeated Bi-Weekly Infusions ff neoGAA (GZ402666) and Alglucosidase Alfa in Treatment Naive Patients With Late Onset Pompe Disease"

Clinical Trial Grant
Duke Scholars

Administered By

School of Medicine

Awarded By

Genzyme Corporation

Start Date

September 1, 2016

End Date

May 18, 2023
 

Administered By

School of Medicine

Awarded By

Genzyme Corporation

Start Date

September 1, 2016

End Date

May 18, 2023